Printer Friendly

HELIX BIOCORE, INC., CHANGES NAME TO ATS MEDICAL, INC. AND UPDATES HUMAN IMPLANT STUDIES

 HELIX BIOCORE, INC., CHANGES NAME TO ATS MEDICAL, INC.
 AND UPDATES HUMAN IMPLANT STUDIES
 MINNEAPOLIS, May 22 /PRNewswire/ -- Manny Villafana, chairman and chief executive officer of Helix BioCore, Inc., announced that the shareholders at the annual meeting approved the change of the company's name to ATS Medical, Inc. The name change will be effective May 22, 1992. The new trading symbol for the company's common stock will be "ATSI" commencing at the opening of trading on May 26.
 At the annual meeting, Villafana also reviewed the progress in the company's recently commenced human implants of the ATS Open Pivot Bileaflet(TM) valve. Villafana reported that implants had been successfully performed in eight major cardiovascular centers located in Germany, Belgium, France and Switzerland. The company intends to continue and expand the international clinical studies throughout 1993 as additional sizes of the valve become available.
 ATS Medical, Inc., is engaged in the development, manufacture and marketing of a new pyrolytic carbon bileaflet mechanical heart valve. The company' common stock is traded on the NASDAQ/National Market System.
 /CONTACT: Manny Villafana or Richard W. Kramp of ATS Medical, 612-553-7736/
 (ATSI) CO: Helix BioCore, Inc.; ATS Medical, Inc. ST: Minnesota IN: MTC SU:


DS -- MN002 -- 3191 05/22/92 09:34 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 22, 1992
Words:208
Previous Article:OHIO DENTAL ASSOCIATION SAYS DENTAL OFFICES ARE SAFE
Next Article:STANDARD PRODUCTS ANNOUNCES CORPORATE OFFICER CHANGES
Topics:


Related Articles
HELIX BIOCORE SELLS BIOCORE DIVISION AND UPDATES STATUS AND PROGRESS OF COMPANY
ATS MEDICAL ANNOUNCES FIRST CLINICAL IMPLANTS
ATS MEDICAL ANNOUNCES SECOND QUARTER RESULTS
VILLAFANA ANNOUNCES ATS MEDICAL, INC. YEAR END RESULTS
VILLAFANA ANNOUNCES ATS MEDICAL, INC. FIRST QUARTER RESULTS
VILLAFANA ANNOUNCES ATS MEDICAL, INC. SECOND QUARTER RESULTS
CLINICAL RESULTS REPORTED ON ATS MEDICAL VALVE
VILLAFANA ANNOUNCES ATS MEDICAL, INC. THIRD QUARTER RESULTS
ATS MEDICAL, INC. ANNOUNCES RECORD FOURTH QUARTER RESULTS AND CONTINUED CLINICAL SUCCESS WITH ITS HEART VALVE
ATS MEDICAL RECEIVES "CE MARK" APPROVAL

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters